This bill establishes new regulations for pharmacy benefit managers and health carriers concerning clinician-administered drugs in Minnesota. It defines key terms such as "affiliated pharmacy" and "clinician-administered drug," and prohibits pharmacy benefit managers and health carriers from requiring that these drugs be covered as a pharmacy benefit. The bill mandates that enrollees have the right to obtain clinician-administered drugs from their chosen healthcare provider or pharmacy without interference or financial incentives from the pharmacy benefit manager or health carrier.

Additionally, the bill outlines requirements for cost-sharing and reimbursement, ensuring that any limitations or costs imposed on enrollees obtaining clinician-administered drugs are consistent with those applied to affiliated pharmacies. It also includes provisions to maintain compliance with federal supply chain security laws and prohibits certain practices related to the dispensing of these drugs. The new regulations will take effect on January 1, 2024.